Literature DB >> 10227013

TGF-beta 1 and IGF-1 expression in atrophic post-menopausal endometrium.

G Loverro1, E Perlino, E Maiorano, G Cormio, R Ricco, E Marra, L Nappi, T Giannini, L Selvaggi.   

Abstract

OBJECTIVES: Endometrial cells may synthetize cytokines and growth factors which may modulate some of the molecular mechanisms of endometrial proliferation and differentiation. PATIENTS AND METHODS: We investigated the role of transforming growth factor beta-1 (TGF-beta 1), insulin-like growth factor-1 (IGF-1) and relative receptors in five tissue samples from atrophic post-menopausal endometria. The control group was represented by proliferative and secretory endometria from 10 healthy, normally-menstratued women. TGF-beta 1 and IGF-1 m-RNA expression was evaluated by Northern hybridization analysis, while TGF-beta 1 and IGF-1 receptors distribution was studied by immunohistochemistry.
RESULTS: In atrophic endometria Northern hybridization analysis showed a significant decrease of IGF-1 expression, and an increase of TGF-beta 1 expression compared to proliferative and secretory endometria. By immunohistochemistry it was demonstrated that TGF-beta 1 and IGF-1 receptors were both localized in cell cytoplasm, mainly in the stromal compartment.
CONCLUSIONS: The results of our study would suggest a possible role of IGF-1 and TGF-beta 1 in maintaining the quiescent differentiative state of atrophic post-menopausal endometrium. The persistence of IGF-1 and TGF-beta 1 receptors in epithelial compartment could play a key role in proliferative response of atrophic endometrium to exogenous hormone replacement therapy (HRT) or endogenous intervening high estrogens levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227013     DOI: 10.1016/s0378-5122(98)00095-4

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  1 in total

1.  Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.

Authors:  Melissa A Merritt; Howard D Strickler; Mark H Einstein; Hannah P Yang; Mark E Sherman; Nicolas Wentzensen; Jurriaan Brouwer-Visser; Maria Jose Cossio; Kathleen D Whitney; Herbert Yu; Marc J Gunter; Gloria S Huang
Journal:  Cancer Causes Control       Date:  2016-04-28       Impact factor: 2.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.